Compare LC & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LC | GRDN |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Finance | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2014 | 2024 |
| Metric | LC | GRDN |
|---|---|---|
| Price | $19.96 | $30.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $22.67 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.5M | 300.5K |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.62 | N/A |
| EPS | ★ 0.89 | 0.28 |
| Revenue | $1,296,102,000.00 | ★ $1,389,638,000.00 |
| Revenue This Year | N/A | $19.50 |
| Revenue Next Year | $16.10 | $0.48 |
| P/E Ratio | ★ $22.32 | $108.26 |
| Revenue Growth | 16.98 | ★ 18.68 |
| 52 Week Low | $7.90 | $17.78 |
| 52 Week High | $20.94 | $37.43 |
| Indicator | LC | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 64.66 | 56.51 |
| Support Level | $18.98 | $28.34 |
| Resistance Level | $20.94 | $31.46 |
| Average True Range (ATR) | 0.68 | 1.04 |
| MACD | 0.23 | 0.07 |
| Stochastic Oscillator | 78.92 | 55.02 |
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.